http://www.ananova.com/news/story/sm_586469.html

The first set of trials for an anti-smoking jab are coming to an end.

The vaccine causes the body to form antibodies against nicotine.

If it is successful a course of five injections could be enough to help a smoker quit.

British firm Xenova is reported to be the first company to have begun tests on an anti-smoking vaccine.

The treatment could be available within five years if clinical trials prove successful.

The Daily Express reports that a US company, Nabi, is also developing a vaccine which works in the same way.

But Dr John St Claire Roberts, the medical director of Xenova, is cautious and warned: "The trial is about the safety, not the effectiveness, of the treatment and sometimes hype can conceal just how far there is to go."

Story filed: 08:50 Monday 13th May 2002

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.